Clinical Trials
5 trialsNCT04960709 2026-04-14
VOLGA
AstraZeneca
Phase 3 Active not recruiting
NCT03924856 2025-08-28
KEYNOTE-866
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT03924895 2025-08-28
KEYNOTE-905
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT05776758 2025-04-16
Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt
Regina Elena Cancer Institute
Phase 3 Active not recruiting
NCT04209114 2024-06-27
A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer
Bristol-Myers Squibb
Phase 3 Completed